Guy P. Nohra, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 500,000 shares at $20.00 ($10.0M) on 2014-10-21, disclosed to the SEC on 2014-10-21.
Open-market purchase of $10.0M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| ALLK | SELL | 2020-06-19 | $1.1M | — | Filing → |
| CBYL | BUY | 2015-04-14 | $4.4M | — | Filing → |
| NEOT | BUY | 2014-11-25 | $980K | — | Filing → |